SKINVIVE™ by JUVÉDERM® is an injectable hyaluronic acid gel approved by the FDA to improve skin smoothness of the cheeks in adults age 21 and older. Small amounts are placed within the skin using microinjections. Unlike fillers used to shape facial contours or replace lost volume, this treatment focuses on cheek skin quality and smoothness.
Your visit begins with a consultation to review your skin, goals, medical history, and previous treatments. Your provider will recommend whether Skinvive is appropriate and how much product is needed. Results vary, are not permanent, and maintenance treatment may be considered.
What Skinvive can address
- Cheek skin texture — improves skin smoothness in the treated cheeks
- Skin quality — an option for patients seeking a smoother-looking cheek surface rather than added facial volume
During treatment, your provider cleans the skin and places small injections across the planned cheek areas. Skinvive contains lidocaine to help reduce discomfort; additional comfort measures can be discussed before treatment.
Frequently asked questions
How is Skinvive different from dermal fillers?
Both may contain hyaluronic acid, but they have different treatment goals and placement. Skinvive is injected within cheek skin to improve smoothness. Volumizing fillers are used to add fullness or contour selected facial areas. Skinvive is not intended to replace a volumizing treatment.
Who is a good candidate?
Skinvive is approved for adults age 21 and older seeking improved cheek skin smoothness. It should not be used in people with a history of severe allergies, multiple severe allergies, or an allergy to lidocaine or the bacterial proteins used in its manufacture. Tell your provider about skin infections, bleeding disorders, medications, prior injections, and any tendency to scar. Safety during pregnancy or breastfeeding has not been established. Your provider will assess suitability before treatment.
When will I see results and how long do they last?
Allow initial swelling and injection-site reactions to settle before judging your result. Improvement was assessed at one month in the clinical study, and cheek smoothness improvements lasted at least six months. Individual results vary, and your provider will discuss follow-up and whether maintenance is appropriate.
What are the possible risks and side effects?
Temporary redness, swelling, bruising, pain, tenderness, firmness, lumps or bumps, discoloration, and itching can occur at injection sites. Infection or delayed inflammatory reactions are possible. Rare but serious complications from injection into a blood vessel include tissue damage, vision changes or blindness, and stroke. Seek immediate medical attention for unusual pain, skin turning white, vision changes, or stroke symptoms during or after treatment.
How should I prepare before treatment?
Arrive with clean skin and tell your provider about all medications, supplements, allergies, skin conditions, and previous aesthetic treatments. Blood-thinning medicines may increase bruising; do not stop prescribed medication without guidance from your prescribing clinician. Treatment may need to be postponed if there is an active infection or inflammation in the area.
What does aftercare involve?
For the first 24 hours, minimize strenuous exercise, extensive sun or heat exposure, and alcohol, which may worsen temporary redness, swelling, or itching. Avoid rubbing or manipulating the treated skin unless your provider advises otherwise. Follow your personalized skincare instructions and contact the clinic if symptoms persist or worsen.
Can Skinvive be combined with other treatments?
Your provider can discuss Skinvive alongside neuromodulators, volumizing fillers, or skin treatments when appropriate. Treatments may need to be spaced apart, particularly procedures that affect the skin’s healing response. A personalized plan helps avoid overlapping irritation and complications.